Navigation Links
Johnson & Johnson Holds 2011 Annual Meeting of Shareholders
Date:4/28/2011

ple in it."

Better Treatments, Broader Reach

Weldon also emphasized the many opportunities the company has to make a difference in life-altering and life-threatening diseases that have not seen significant advancements in a number of years. In this category, he highlighted Alzheimer's disease, saying there was "an enormous unmet medical need in addressing this disease."  Weldon described the company's commitments and investments in helping to advance a promising new compound, bapineuzumab, which, he said, may have "the potential to actually address the underlying pathology of Alzheimer's disease."

Gorsky and McCoy discussed how the company is developing new innovations for many of the world's most pressing health needs, while also expanding its reach to serve a greater number of people around the world.

McCoy highlighted Consumer innovations including NICORETTE® QuickMist, recently launched in the U.K. and clinically proven to relieve nicotine cravings in as little as 60 seconds, and NEUTROGENA® Naturals, combining the benefits of natural ingredients with the effectiveness consumers expect from NEUTROGENA®.

In the company's Pharmaceuticals segment, McCoy described four innovative medicines that are currently in regulatory review in the United States and/or Europe – abiraterone acetate for advanced prostate cancer, telaprevir for Hepatitis C, rivaroxaban for preventing blood clots, and TMC 278 for HIV.

McCoy noted that the number of current U.S. regulatory submissions – seven – is exceptional, and that "these medicines represent transformational advances over the current standards of care for patients living with serious diseases."

The existing pharmaceuticals business, McCoy added, which began the year with a strong first quarter, was strengthened by the recent expansion of the Immunology portfolio as a result of the return of rights for REMICADE® and SIMPONI® i
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shareholders to Challenge Johnson & Johnsons Support for Left-Wing Policy Agenda: CEO William C. Weldon to Be Questioned on Firms Failure to Disclose Financial Information on Firms ObamaCare Lobbying It Pledged to Release Last Year
2. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
3. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
4. Johnson & Johnson Reports 2011 First-Quarter Results
5. Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
6. AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)
7. Johnson & Johnson Announces Settlement With U.S. Department of Justice and U.S. Securities and Exchange Commission
8. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
9. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
10. Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs
11. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... , September 19, 2014 ... Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture ... Users (Hospitals), Advanced technologies - Global Forecast to ... is poised to reach $19,786.3 Million by 2019 ... of 6.8% from 2014 to 2019. ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4
(Date:9/19/2014)... (PRWEB) September 19, 2014 The ... important partnership with the National Fire Protection Association ... The collaboration, formalized today in a Memorandum of ... Members, factories, workers and other stakeholders with information, ... help protect the health and safety of workers ...
(Date:9/19/2014)... Lipitor lawsuits ( http://www.thelipitorlawsuit.com/ ) ... develop Type 2 diabetes continue to move forward in ... Court, District of South Carolina, Bernstein Liebhard LLP reports. ... 2014, discovery is underway and moving forward in the ... Inc., the manufacturer of Lipitor, has produced millions of ...
(Date:9/19/2014)... MetroMD, a leading anti-ageing clinic has called its ... health. This therapy has grown tremendously across USA in the ... safe and dependable. It has far reaching benefits for ageing ... a very healthy and active lifestyle even beyond their middle ... senior therapist at MetroMD said, “HGH or Human Growth hormones ...
(Date:9/19/2014)... intact cells to treat and cure disease is ... is hindered by the inability of doctors and scientists ... these cells in patients without resorting to invasive procedures, ... 17 in the online journal Magnetic Resonance in ... Diego School of Medicine, University of Pittsburgh and elsewhere ...
(Date:9/19/2014)... 2014 "I have difficulty putting in ... to stretching the skin around my eyes during the ... me to design a more convenient method of performing ... provides a quicker, easier, more sanitary method of putting ... this task manually, saves time and effort, and helps ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:A better way to track emerging cell therapies using MRIs 2
... to open its 100-bed super-specialty hospital in Oman by the ... of Oman newspaper quoted Apollo Medical Centre (AMC) managing director ... first of its kind in the private sector in Oman. ... between super-specialty hospitals and polyclinics in the Gulf nation. ...
... today told captains of the bio-tech industry that generation of ... the sector, may not be possible. // ,'One ... far cry,' Sibal said at the inauguration of 'Bio 2006', ... ,Unlike the IT sector based on services, biotechnology sector ...
... to the researcher Steve Allen of Stanford University in California, ... fuel-efficient engines in the universe, from a research//. ... billion miles (1.6 billion km) on a gallon (4.5 litres) ... gas of the galaxies, can measure hundreds or even thousands ...
... Age-related Macular Degeneration (AMD) is one of the primary causes ... the disease may partly depend upon his diet.// The quality ... rather than the quantity, according to a research led ... and Vision Research , at Tufts University. Their findings ...
... calpain can play a key role in regulating cell death, ... by these scientists //that calpain may be used to promote ... prevent cell death such as in neuronal cells in ... a Professor of Pathology and Molecular Medicine with the Cancer ...
... for the elderly was planned as a new deal for ... //for everyone in old age. But now this policy is ... councils are alleging that they have already run out of ... was reported that more than 200 pensioners were denied their ...
Cached Medicine News:Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 2Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 3Health News:Protein’s role in regulating cell death sets direction for Alzheimer’s, Parkinson’s and cancer resea 2
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: